Enter to open, tab to navigate, enter to select
Antitrust risk-shifting provisions in Akorn, Inc./Hi-Tech Pharmacal Co., Inc. merger agreement
| August 26, 2013 • Antitrust Risk-shifting • $640 million |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.